My NCBI | Sign In
RSS Settings
  • Search: Calmy Alexandra[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 34

    1.

    Infrequent Replication of Parvovirus B19 and Erythrovirus Genotypes 2 and 3 among HIV-Infected Patients with Chronic Anemia.

    Ferry T, Hirschel B, Dang T, Meylan P, Delhumeau C, Rauch A, Weber R, Elzi L, Bernasconi E, Schmid P, Calmy A.

    Clin Infect Dis. 2009 Dec 1. [Epub ahead of print]PMID: 19951110 [PubMed - as supplied by publisher]Related articles

    2.

    Safety and efficacy of once-daily nevirapine dosing: a multicohort study.

    Calmy A, Vallier N, Nguyen A, Lange JM, Battegay M, de Wolf F, Reiss P, Lima VD, Hirschel B, Hogg RS, Yip B, Montaner JS, Wit FW; Swiss HIV Cohort study; HAART Observational Medical Evaluation and Research Cohort; Netherlands ATHENA Observational Cohort.

    Antivir Ther. 2009;14(7):931-8.PMID: 19918097 [PubMed - in process]Related articles

    3.

    Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.

    Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A.

    J Infect Dis. 2009 Dec 1;200(11):1746-54.PMID: 19874178 [PubMed - in process]Related articles

    4.

    Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings.

    Johannessen A, Trøseid M, Calmy A.

    J Antimicrob Chemother. 2009 Dec;64(6):1126-9. Epub 2009 Sep 23.PMID: 19776036 [PubMed - in process]Related articles

    5.

    Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.

    Kovari H, Ledergerber B, Peter U, Flepp M, Jost J, Schmid P, Calmy A, Mueller NJ, Muellhaupt B, Weber R; Swiss HIV Cohort Study.

    Clin Infect Dis. 2009 Aug 15;49(4):626-35.PMID: 19589079 [PubMed - indexed for MEDLINE]Related articles

    6.

    Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

    Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N.

    Antivir Ther. 2009;14(3):339-47.PMID: 19474468 [PubMed - indexed for MEDLINE]Related articles

    7.

    A new era of antiretroviral drug toxicity.

    Calmy A, Hirschel B, Cooper DA, Carr A.

    Antivir Ther. 2009;14(2):165-79. Review.PMID: 19430091 [PubMed - indexed for MEDLINE]Related articles

    8.

    HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial.

    Calmy A, Gayet-Ageron A, Montecucco F, Nguyen A, Mach F, Burger F, Ubolyam S, Carr A, Ruxungtham K, Hirschel B, Ananworanich J; STACCATO Study Group.

    AIDS. 2009 May 15;23(8):929-39.PMID: 19425222 [PubMed - in process]Related articles

    9.

    Rationing antiretroviral therapy in Africa--treating too few, too late.

    Ford N, Mills E, Calmy A.

    N Engl J Med. 2009 Apr 30;360(18):1808-10. No abstract available. PMID: 19403900 [PubMed - indexed for MEDLINE]Related articles

    10.

    The marriage of science and optimized HIV care in resource-limited settings.

    Calmy A, Pizzocolo C, Pizarro L, Brücker G, Murphy R, Katlama C; Strategies in Resource-Limited Settings Working Group.

    AIDS. 2008 Nov 12;22(17):2227-30. No abstract available. PMID: 18981761 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.

    Elliott JH, Lynen L, Calmy A, De Luca A, Shafer RW, Zolfo M, Clotet B, Huffam S, Boucher CA, Cooper DA, Schapiro JM.

    AIDS. 2008 Oct 18;22(16):2053-67. Review. No abstract available. PMID: 18753937 [PubMed - indexed for MEDLINE]Related articles

    12.

    Monitoring of antiretroviral therapy in low-resource settings.

    Lawn SD, Bekker LG, Calmy A, Wood R.

    Lancet. 2008 Jul 26;372(9635):287-8; author reply 289. No abstract available. PMID: 18657697 [PubMed - indexed for MEDLINE]Related articles

    13.

    How developing world concerns need to be part of drug development plans: a case study of four emerging antiretrovirals.

    van Roey J, von Schoen-Angerer T, Ford N, Calmy A.

    Drug Discov Today. 2008 Jul;13(13-14):601-5. Epub 2008 Jun 17. Review.PMID: 18598916 [PubMed - indexed for MEDLINE]Related articles

    14.

    Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.

    Pujades-Rodríguez M, O'Brien D, Humblet P, Calmy A.

    AIDS. 2008 Jul 11;22(11):1305-12.PMID: 18580610 [PubMed - indexed for MEDLINE]Related articles

    15.

    Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon.

    Kouanfack C, Laurent C, Peytavin G, Ciaffi L, Ngolle M, Nkene YM, Essomba C, Calmy A, Mpoudi-Ngolé E, Delaporte E, Koulla-Shiro S; French National Agency for Research on AIDS 1274 Study Group.

    J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):216-9.PMID: 18520681 [PubMed - indexed for MEDLINE]Related articles

    16.

    Initial treatment for HIV infection--an embarrassment of riches.

    Hirschel B, Calmy A.

    N Engl J Med. 2008 May 15;358(20):2170-2. No abstract available. PMID: 18480210 [PubMed - indexed for MEDLINE]Related articles

    17.

    Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.

    Laurent C, Bourgeois A, Mpoudi-Ngolé E, Ciaffi L, Kouanfack C, Mougnutou R, Nkoué N, Calmy A, Koulla-Shiro S, Delaporte E.

    AIDS Res Hum Retroviruses. 2008 Mar;24(3):393-9.PMID: 18327976 [PubMed - indexed for MEDLINE]Related articles

    18.

    Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.

    Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, Cooper DA, Emery S; INITIO Trial International Coordinating Committee.

    AIDS. 2007 Nov 30;21(18):2445-53.PMID: 18025881 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD).

    Srasuebkul P, Calmy A, Zhou J, Kumarasamy N, Law M, Lim PL; TREAT Asia HIV Observational Database.

    AIDS Res Ther. 2007 Sep 17;4:18.PMID: 17868478 [PubMed]Related articlesFree article

    20.

    Clinical update: adverse effects of antiretroviral therapy.

    Calmy A, Hirschel B, Cooper DA, Carr A.

    Lancet. 2007 Jul 7;370(9581):12-4. No abstract available. PMID: 17617255 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity